WearOptimo
Category: AI in Healthcare
WearOptimo develops next-generation wearable sensors for personal health monitoring, focusing on hydration and other health metrics. WearOptimo was founded in 2018. The company is led by Professor Mark Kendall. Based in Brisbane, Australia. Team size: 26. Total funding raised: A$44 million+ (more than A$44 million raised from private and public sectors). Latest round: $8 million investment round backed by Mark Webber and others. Key investors include Mark Webber, Aspen Medical.
- Founded
- 2018
- Headquarters
- Brisbane, Australia
- Team size
- 26
- Total funding
- A$44 million+ (more than A$44 million raised from private and public sectors)
Value proposition
WearOptimo's Microwearable sensors provide real-time, non-invasive monitoring of hydration and other health metrics, offering significant improvements over traditional methods.
Products and solutions
Hydration Microwearable Sensor
Unique value
WearOptimo's sensors use micro-electrodes that penetrate the outer skin layer to access bio-signals that surface-based products cannot measure.
Target customer
Industries such as mining, military, elite sports, and aged care, as well as general consumers interested in health monitoring.
Industries served
Healthcare, Sports, Aged Care, Mining
Technology advantage
The technology offers real-time, continuous monitoring of hydration and other health metrics, which is crucial for timely interventions.
How they differentiate
WearOptimo's technology provides continuous, real-time monitoring with micro-electrodes, offering more precise data than competitors.
Main competitors
Nix, Garmin (with hydration monitoring features)
Key partnerships
Aspen Medical, Australian National University
Major milestones
Started clinical trials for hydration sensor, Opened Advanced Manufacturing Facility in Brisbane, Entered AU$30 million partnership to mass produce microwearable sensors, 2025: Successful completion of clinical pilot study establishing proof of concept for hydration Microwearable device, 2025: Introduced World-Class Advisory Board, 2026: Additional clinical studies and real-world field trials commenced, 2026: Three new granted patents expanding IP estate to 15 granted patents
Growth metrics
Currently in clinical trials with plans for commercialization.
Market positioning
Positioned as a leader in wearable health technology for hydration monitoring.
Geographic focus
Global, with a focus on markets that benefit from hydration monitoring.
Patents and IP
15 granted patents related to Microwearable technology
About Professor Mark Kendall
Professor Mark Kendall is a biomedical engineer, inventor, scientist, and entrepreneur with over 25 years of experience in creating medical technologies to tackle key global health challenges. He is the founder and CEO of WearOptimo and a Vice-Chancellor's Entrepreneurial Professor at the Australian National University. His work has led to the development of the Nanopatch, a needle-free vaccine delivery system.
Official website: https://wearoptimo.com/